155 results
424B7
EXAS
Exact Sciences Corp.
8 May 24
Prospectus with selling stockholder info
5:08pm
and diagnostic tests, Exact Sciences Corporation (together with its subsidiaries, “Exact,” “we,” “us,” “our” or the “Company”) gives patients and health care professionals
8-K
EX-99.1
EXAS
Exact Sciences Corp.
8 May 24
Exact Sciences Announces First-Quarter 2024 Results
4:08pm
provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing
8-K
EX-99.1
EXAS
Exact Sciences Corp.
17 Apr 24
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
4:01pm
gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard®
8-K
pvo4z6qjy1 h59r5m1w
15 Apr 24
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
6:02am
8-K
EX-99.1
c61gb efdx
15 Apr 24
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
6:02am
8-K
EX-99.1
gv6i9p3sn vp057
21 Feb 24
Exact Sciences Announces Fourth Quarter 2023 Results
4:40pm
8-K
EX-99.1
e1rl das3
8 Jan 24
Exact Sciences Announces Preliminary Fourth Quarter 2023 Results
7:03am
8-K
EX-99
cpy k6z518
1 Nov 23
Exact Sciences Announces Third-Quarter 2023 Results Reports record revenue, delivers more than a million test results, raises full-year guidance
4:09pm
8-K
EX-99
3nfl4ccb9w0b1tq
1 Aug 23
Exact Sciences Announces Second-Quarter 2023 Results Reports record results, generates positive free cash flow, raises full-year guidance
4:08pm
8-K
EX-99.1
kbvu0oukoeo0 ykg
21 Jun 23
Regulation FD Disclosure
10:33am
8-K
EX-10.1
65z30sbx1mf054eimd
30 Jun 22
Entry into a Material Definitive Agreement
7:34am
8-K
EX-10.2
24743 q5yhhz9jj
30 Jun 22
Entry into a Material Definitive Agreement
7:34am
8-K
EX-10.3
7llfff6 c24v8bcwnt6
30 Jun 22
Entry into a Material Definitive Agreement
7:34am